Results 161 to 170 of about 12,292,416 (404)
Molecular Oncology, EarlyView.Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva +5 more
wiley +1 more source
CHEMICAL CHANGES OF THE BLOOD UNDER THE INFLUENCE OF DRUGS
, 1922 Harry V. Atkinson, Harold N. Ets
openalex +1 more source
Self-depression of the Subcutaneous Absorption of Drugs due to Release of Histamine [PDF]
, 1958 Jens Schou
openalex +1 more source
Molecular Oncology, EarlyView.Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon +13 more
wiley +1 more source
The Formulation and Review of Regulations under the Food, Drug, and Cosmetic Act
, 1939 Ralph F. Fuchs
openalex +2 more sources
The ACTION of CERTAIN DRUGS and MINERAL WATERS on the SECRETION and COMPOSITION of HUMAN BILE: An EXPERIMENTAL INVESTIGATION [PDF]
, 1898 W H Bain
openalex +1 more source
Molecular Oncology, EarlyView.In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source
Proceedings Relating to the Organization of the National Drug Trade Conference [PDF]
, 1913 C. M. Woodruff
openalex +1 more source
Molecular Oncology, EarlyView.In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source